Stephanie Howe Guarino, MD
Hematology/OncologyInsurance Accepted
- Aetna Better Health PA Kids HMO
 - Aetna HMO
 - Aetna PPO/POS/EPO
 - Amerihealth Caritas Delaware
 - Amerihealth Caritas Delaware VIP Next (DE - All Sites) (PA - Delaware & Chester County Sites & TJU Sites Only)
 - Carefirst MD Community Health Plan Mcaid
 - Cigna/Great West HMO EPO POS
 - Cigna/Great West PPO
 - Delaware First Health
 - Delaware Medicaid/Diamond State
 - Delaware Medicare
 - Fidelis Care NJ Medicaid HMO
 - First Health/Affordable PPO
 - Geisinger Health Plan Commercial
 - Global Medical Managment DE/PA
 - Health Partners Medicaid/Kidz Partner HMO
 - Highmark Blue Cross Blue Shield of Delaware
 - Highmark Blue Cross Blue Shield of Delaware *PA Loc Contiguous to DE*
 - Highmark Blue Cross Blue Shield of Pennsylvania
 - Highmark Medicaid Health Options
 - Horizon Blue Cross Blue Shield of New Jersey
 - Independance Blue Cross/Amerihealth/Keystone Health Plan
 - Independence Blue Cross/Amerihealth/Keystone Health Plan
 - Insurance Administrators of America
 - INTEGRA Administrative Group (ClaimsBridge)
 - Keystone First CHIP
 - Keystone First Medicaid HMO
 - Lifetrac Transplant
 - Maryland Medicaid
 - Multiplan PPO
 - National Transplant (Humana)
 - New Jersey Medicaid
 - Olympus Managed Healthcare PPO DE/PA
 - Pennsylvania Medicaid
 - Preferred Healthcare PPO
 - Priority Partners John Hopkins
 - Private Health Care Systems (PHCS)
 - Six Degrees Health Transplant
 - Six Degrees Health-Lucent
 - Star Healthcare Network
 - Three Rivers Provider Network
 - Tricare/Humana Military Health Services/CHAMPVA
 - United Healthcare HMO/POS/PPO/EPO
 - UPMC Medicaid/CHIP
 - US Family Health Plan
 - Wellpoint Maryland Medcaid
 
- Bone Tumors
 - Cancer Care
 - Leukemia
 - Lymphoma
 - Solid Tumors
 
- 
            
AML in Distinct Age-Defined Populations of Infants, Adolescents and Young Adults; Pediatric Oncology; (2024).
 - 
            
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel; Annals of Hematology; (2024).
 - 
            
COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data<sup>â„¢</sup>(CRWD); Journal of Clinical and Translational Science; (2023).
 - 
            
Peer Mediated Groups: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease; Delaware Journal of Public Health; (2022).
 - 
            
How to utilize new therapies for sickle cell disease; Hematology (United States); (2022).
 - 
            
Reflections from physician scientists on the front lines of covid-19; Delaware Journal of Public Health; (2020).
 
- English